U.S. Senate Finance Committee Chair Ron Wyden (D-OR) has announced the expansion of his ongoing investigation into the tax practices of multinational pharmaceutical companies with a new letter sent to the CEO of Pfizer on Monday 20 May 2024. --- Wyden Expands Big Pharma Tax Investigation with Pfizer Inquiry New Letter to Pfizer CEO Builds on Three-Year Committee Investigation; The U.S. Is By Far Pfizer's Largest Market, But Pfizer Regularly Books All Taxable Income Offshore Washington, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., expanded his ongoing investigation into Big Pharma's tax avoidance and profit shifting with a new...